第四军医大学学报
第四軍醫大學學報
제사군의대학학보
JOURNAL OF THE FOURTH MILITARY MEDICAL UNIVERSITY
2001年
6期
511-513
,共3页
张传山%王文亮%彭玮丹%胡沛臻%柴玉波%张衍国
張傳山%王文亮%彭瑋丹%鬍沛臻%柴玉波%張衍國
장전산%왕문량%팽위단%호패진%시옥파%장연국
肝肿瘤%bcl-2%核酶%脱噬作用
肝腫瘤%bcl-2%覈酶%脫噬作用
간종류%bcl-2%핵매%탈서작용
目的 观察bcl-2核酶对SMMC-7721细胞的作用,探讨bcl-2表达水平的改变对细胞端粒酶活性的影响.方法 经脂质体介导的方法将PMTr-neo(正向bcl-2核酶真核表达载体)导入SMMC7721细胞中,细胞克隆转移扩大培养后,采用TUNEL,TRAP-PCR-ELISA,免疫组化技术结合图像分析技术检测SMMC7721/PMTr-neo细胞凋亡、细胞端粒酶活性及P16,P21的改变.结果 较对照组SMMC7721/PMTr-neo细胞Bcl-2表达水平显著下降,伴有显著细胞凋亡现象;同时端粒酶活性下降,P16,P21表达水平显著增加.结论 bcl-2核酶可促进SMMC7721细胞发生凋亡,并降低细胞端粒酶活性,提示Bcl-2表达水平的改变对细胞端粒酶活性有一定的影响.
目的 觀察bcl-2覈酶對SMMC-7721細胞的作用,探討bcl-2錶達水平的改變對細胞耑粒酶活性的影響.方法 經脂質體介導的方法將PMTr-neo(正嚮bcl-2覈酶真覈錶達載體)導入SMMC7721細胞中,細胞剋隆轉移擴大培養後,採用TUNEL,TRAP-PCR-ELISA,免疫組化技術結閤圖像分析技術檢測SMMC7721/PMTr-neo細胞凋亡、細胞耑粒酶活性及P16,P21的改變.結果 較對照組SMMC7721/PMTr-neo細胞Bcl-2錶達水平顯著下降,伴有顯著細胞凋亡現象;同時耑粒酶活性下降,P16,P21錶達水平顯著增加.結論 bcl-2覈酶可促進SMMC7721細胞髮生凋亡,併降低細胞耑粒酶活性,提示Bcl-2錶達水平的改變對細胞耑粒酶活性有一定的影響.
목적 관찰bcl-2핵매대SMMC-7721세포적작용,탐토bcl-2표체수평적개변대세포단립매활성적영향.방법 경지질체개도적방법장PMTr-neo(정향bcl-2핵매진핵표체재체)도입SMMC7721세포중,세포극륭전이확대배양후,채용TUNEL,TRAP-PCR-ELISA,면역조화기술결합도상분석기술검측SMMC7721/PMTr-neo세포조망、세포단립매활성급P16,P21적개변.결과 교대조조SMMC7721/PMTr-neo세포Bcl-2표체수평현저하강,반유현저세포조망현상;동시단립매활성하강,P16,P21표체수평현저증가.결론 bcl-2핵매가촉진SMMC7721세포발생조망,병강저세포단립매활성,제시Bcl-2표체수평적개변대세포단립매활성유일정적영향.
AIM To observe the effect of bcl-2 ribozyme on SMMC7721 cells andto investigate bcl-2 expression on cellular apoptosis and telomerase activity. METHODS PMTr-neo (sense bcl-2 ribozyme eucaryotic expression vector) was introduced into SMMC7221 cells by using lipofectin media-tion, after cloning TUNEL and TRAP in combination of ELISA and IHC in combination of imaging analysis was used to determine SMMC7721/PMTr-neo apoptosis and telomerase activity. RESULTS Compared with control, SMMC7721/PMTr-neo presented a significant drop in bcl-2 expression and an increase in P16 and P21 expression, accompanied by a decline in remarkable apoptosis and telomerase activity. CONCLUSION bcl-2 ribozyme promotes apoptosis of SMMC7721 cells and reduces telomerase activity. These provide a theoretical basis for applying antisense technique to treatment of hepatocarcinoma.